Back

Select your region

Schedule a cord blood consultation

Make an appointment

Stem Cells
Therapies

Stem Cells Therapies

The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).

FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.

Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.

Check the full list of patients who received stem cell therapy derived from FamiCord labs.

List last update: 06.2026

List of patients who received stem cells from FamiCord Group laboratories

List of patients who received stem cells from FamiCord Group laboratories
Lp. Source Source type Diagnosis Medical field Year of application Therapy Country Age of recipient
701 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 57
702 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3
703 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3
704 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 2
705 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5
706 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 11
707 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 54
708 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 78
709 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6
710 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 58
711 Cord Tissue Autologous Autism Neurology 2025 Experimental Therapy Romania 5
712 Cord Tissue Allogeneic – Related Autism Neurology 2025 Experimental Therapy Romania 5
713 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 4
714 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7
715 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7
716 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 25
717 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6
718 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 62
719 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2025 Experimental Therapy Poland 67
720 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7
721 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2025 Experimental Therapy Poland 61
722 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5
723 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6
724 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1
725 Cord Tissue Allogeneic – Unrelated Myelitis Neurology 2025 Experimental Therapy Poland 38
726 Cord Tissue Allogeneic – Unrelated Anemia Neurology 2025 Experimental Therapy Poland 3
727 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 6
728 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7
729 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2025 Experimental Therapy Poland 5
730 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1
731 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1
732 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 5
733 Cord Tissue Allogeneic – Unrelated Progressive bulbar palsy Neurology 2025 Experimental Therapy Poland 63
734 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 15
735 Cord Tissue Allogeneic – Unrelated GvHD Immunology 2025 Experimental Therapy Poland 13
736 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 48
737 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 51
738 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2025 Experimental Therapy Poland 12
739 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 10
740 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 8
741 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3
742 Cord Tissue Allogeneic – Unrelated Cerebral Infarction Neurology 2025 Experimental Therapy Poland 57
743 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 7
744 Cord Tissue Allogeneic – Unrelated Cerebellar Syndrome Neurology 2025 Experimental Therapy Poland 43
745 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 61
746 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2025 Experimental Therapy Poland 57
747 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 1
748 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2025 Experimental Therapy Poland 7
749 Cord Tissue Allogeneic – Unrelated Autism Neurology 2025 Experimental Therapy Poland 3
750 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 5
751 Cord Blood Autologous Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
752 Cord Blood Allogeneic – Related Thalassemia Major Hematology 2025 Standard Therapy Turkey 6
753 Cord Blood Allogeneic – Related Cerebral Palsy Neurology 2025 Experimental Therapy Portugal 1
754 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Romania 5
755 Cord Blood Allogeneic Acute lymphoblastic leukemia Hematology 2025 Standard Therapy Poland 13
756 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5
757 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 7
758 Cord Blood Allogeneic Thalassemia Major Hematology 2025 Standard Therapy Turkey 10
759 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4
760 Cord Blood Autologous Cerebral Palsy Neurology 2025 Experimental Therapy Poland 3
761 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5
762 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 2
763 Cord Blood Autologous Unbalanced AVSD Cardiovascular 2025 Experimental Therapy Poland 5
764 Cord Blood Allogeneic – Related Relapsed Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 8
765 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 10
766 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5
767 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 4
768 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5
769 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 5
770 Cord Blood Autologous Autism Neurology 2025 Experimental Therapy Poland 3
771 Cord Blood Allogeneic – Related D57.1 Sickle Cell Anemia Hematology 2025 Standard Therapy Turkey 5
772 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 66
773 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
774 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 71
775 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 72
776 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 47
777 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Ukraine 43
778 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 49
779 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 51
780 Bone Marrow Family Allogeneic Philadelphia – positive Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 61
781 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 58
782 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy NETHERLANDS 63
783 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 65
784 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 63
785 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
786 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy France 71
787 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 51
788 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
789 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 54
790 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 16
791 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 61
792 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 61
793 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 70
794 Bone Marrow Family Allogeneic PostET Myelofibrosis Hematology 2025 Standard Therapy Netherlands 21
795 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 68
796 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia/ Mielodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
797 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 60
798 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 33
799 Bone Marrow Family Allogeneic Muscular Dystrophy Association Hematology 2025 Standard Therapy United Kingdom 75
800 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 72